Home

Sandesh Mahatme

CIK 1511034 · CFO · last filed 2026-06-09

Sandesh Mahatme is a CFO who has filed 49 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for CRSP, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$50.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $593.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$593.7K

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$50.71M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRSP Director — $47.76 — $0 3 2026-06-09
VOR CFO 0 $19.83 $0 $0 2 2025-12-09
Spyre Therapeutics, Inc. (AGLE) Delisted Director — $12.01 — $0 7 2022-06-09
SRPT EVP, CFO & CBO 30,851 $15.65 $482.8K -$50.71M 29 2020-07-09
FLXN Director 4,500 $24.64 $110.9K $0 8 2020-06-12

Recent Filings

49 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-09 CRSP Grant (A) — $0 EDGAR
2025-12-09 VOR Mixed −694,137 $0 EDGAR
2025-07-10 VOR Grant (A) +13,882,750 $0 EDGAR
2025-06-06 CRSP Grant (A) — $0 EDGAR
2024-05-31 CRSP Grant (A) — $0 EDGAR
2022-06-09 Spyre Therapeutics, Inc. (AGLE) Delisted Grant (A) — $0 EDGAR
2021-06-09 Spyre Therapeutics, Inc. (AGLE) Delisted Grant (A) — $0 EDGAR
2020-07-09 SRPT Mixed −16,619 $74.9K EDGAR
2020-06-12 FLXN Grant (A) +4,500 $0 EDGAR
2020-06-10 Spyre Therapeutics, Inc. (AGLE) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 49
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.